D-0003-2026 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- October 15, 2025
- Initiation Date
- September 22, 2025
- Termination Date
- January 5, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,669 syringes
Product Description
Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.
Reason for Recall
Lack of assurance of sterility.
Distribution Pattern
Nationwide in the US
Code Information
Lot # 20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025